| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4082535
[patent_doc_number] => 06054467
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosis'
[patent_app_type] => 1
[patent_app_number] => 8/675887
[patent_app_country] => US
[patent_app_date] => 1996-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 20437
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054467.pdf
[firstpage_image] =>[orig_patent_app_number] => 675887
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/675887 | Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosis | Jul 4, 1996 | Issued |
Array
(
[id] => 3824696
[patent_doc_number] => 05759792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same'
[patent_app_type] => 1
[patent_app_number] => 8/667970
[patent_app_country] => US
[patent_app_date] => 1996-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1525
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759792.pdf
[firstpage_image] =>[orig_patent_app_number] => 667970
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/667970 | Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same | Jun 18, 1996 | Issued |
Array
(
[id] => 3929682
[patent_doc_number] => 05877294
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same'
[patent_app_type] => 1
[patent_app_number] => 8/667971
[patent_app_country] => US
[patent_app_date] => 1996-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 1525
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877294.pdf
[firstpage_image] =>[orig_patent_app_number] => 667971
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/667971 | Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same | Jun 18, 1996 | Issued |
Array
(
[id] => 3931603
[patent_doc_number] => 05939277
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Detection and treatment of breast and gynecological cancer'
[patent_app_type] => 1
[patent_app_number] => 8/628687
[patent_app_country] => US
[patent_app_date] => 1996-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 33
[patent_no_of_words] => 12762
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939277.pdf
[firstpage_image] =>[orig_patent_app_number] => 628687
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/628687 | Detection and treatment of breast and gynecological cancer | Jun 13, 1996 | Issued |
Array
(
[id] => 3922563
[patent_doc_number] => 05914238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-22
[patent_title] => 'Materials and methods for detection of breast cancer'
[patent_app_type] => 1
[patent_app_number] => 8/658639
[patent_app_country] => US
[patent_app_date] => 1996-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9508
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/914/05914238.pdf
[firstpage_image] =>[orig_patent_app_number] => 658639
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/658639 | Materials and methods for detection of breast cancer | Jun 4, 1996 | Issued |
| 08/648195 | CHEMICALLY MODIFIED BINDING PROTEIN | May 21, 1996 | Abandoned |
Array
(
[id] => 3981549
[patent_doc_number] => 05948885
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Mitogen-activated protein kinase p38-2 and methods of use therefor'
[patent_app_type] => 1
[patent_app_number] => 8/651940
[patent_app_country] => US
[patent_app_date] => 1996-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8650
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948885.pdf
[firstpage_image] =>[orig_patent_app_number] => 651940
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/651940 | Mitogen-activated protein kinase p38-2 and methods of use therefor | May 19, 1996 | Issued |
| 08/635344 | MUTATED RAS PEPTIDES FOR GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES | Apr 18, 1996 | Abandoned |
Array
(
[id] => 3808578
[patent_doc_number] => 05788964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Method for sensitization of cancer cells for killer cell mediated lysis'
[patent_app_type] => 1
[patent_app_number] => 8/596121
[patent_app_country] => US
[patent_app_date] => 1996-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3619
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/788/05788964.pdf
[firstpage_image] =>[orig_patent_app_number] => 596121
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/596121 | Method for sensitization of cancer cells for killer cell mediated lysis | Apr 14, 1996 | Issued |
| 08/631031 | NOVEL METHODS FOR THE PREDICTION AND EARLY DETECTION OF PROSTATIC ADENOCARCINOMA | Apr 11, 1996 | Abandoned |
Array
(
[id] => 4067483
[patent_doc_number] => 06068830
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen'
[patent_app_type] => 1
[patent_app_number] => 8/569206
[patent_app_country] => US
[patent_app_date] => 1996-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 11548
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/068/06068830.pdf
[firstpage_image] =>[orig_patent_app_number] => 569206
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/569206 | Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen | Apr 10, 1996 | Issued |
Array
(
[id] => 3780473
[patent_doc_number] => 05821049
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'In vitro assay for identification of carcinogens'
[patent_app_type] => 1
[patent_app_number] => 8/628758
[patent_app_country] => US
[patent_app_date] => 1996-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7138
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821049.pdf
[firstpage_image] =>[orig_patent_app_number] => 628758
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/628758 | In vitro assay for identification of carcinogens | Apr 4, 1996 | Issued |
Array
(
[id] => 4225316
[patent_doc_number] => 06011137
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Identification and isolation of novel polypeptides having WW domains and methods of using same'
[patent_app_type] => 1
[patent_app_number] => 8/630916
[patent_app_country] => US
[patent_app_date] => 1996-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 37827
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/011/06011137.pdf
[firstpage_image] =>[orig_patent_app_number] => 630916
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/630916 | Identification and isolation of novel polypeptides having WW domains and methods of using same | Apr 2, 1996 | Issued |
Array
(
[id] => 3941797
[patent_doc_number] => 05976818
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope'
[patent_app_type] => 1
[patent_app_number] => 8/626675
[patent_app_country] => US
[patent_app_date] => 1996-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5137
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976818.pdf
[firstpage_image] =>[orig_patent_app_number] => 626675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/626675 | Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope | Apr 1, 1996 | Issued |
| 08/624190 | SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES | Mar 27, 1996 | Abandoned |
Array
(
[id] => 3908982
[patent_doc_number] => 06001580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Method for assaying ERK2 map kinase'
[patent_app_type] => 1
[patent_app_number] => 8/622277
[patent_app_country] => US
[patent_app_date] => 1996-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 20575
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001580.pdf
[firstpage_image] =>[orig_patent_app_number] => 622277
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/622277 | Method for assaying ERK2 map kinase | Mar 26, 1996 | Issued |
Array
(
[id] => 4149139
[patent_doc_number] => 06103237
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Stable variant hK2 polypeptide'
[patent_app_type] => 1
[patent_app_number] => 8/622046
[patent_app_country] => US
[patent_app_date] => 1996-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 22125
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103237.pdf
[firstpage_image] =>[orig_patent_app_number] => 622046
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/622046 | Stable variant hK2 polypeptide | Mar 25, 1996 | Issued |
Array
(
[id] => 3884295
[patent_doc_number] => 05723302
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Detection of prostate-specific antigen in breast tumors'
[patent_app_type] => 1
[patent_app_number] => 8/607777
[patent_app_country] => US
[patent_app_date] => 1996-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 12980
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723302.pdf
[firstpage_image] =>[orig_patent_app_number] => 607777
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/607777 | Detection of prostate-specific antigen in breast tumors | Feb 26, 1996 | Issued |
Array
(
[id] => 4041625
[patent_doc_number] => 05911995
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'EGF-genistein conjugates for the treatment of cancer'
[patent_app_type] => 1
[patent_app_number] => 8/602186
[patent_app_country] => US
[patent_app_date] => 1996-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 9726
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/911/05911995.pdf
[firstpage_image] =>[orig_patent_app_number] => 602186
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/602186 | EGF-genistein conjugates for the treatment of cancer | Feb 15, 1996 | Issued |
Array
(
[id] => 3766484
[patent_doc_number] => 05773224
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Immunoselection system for cell elution'
[patent_app_type] => 1
[patent_app_number] => 8/598560
[patent_app_country] => US
[patent_app_date] => 1996-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4919
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773224.pdf
[firstpage_image] =>[orig_patent_app_number] => 598560
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/598560 | Immunoselection system for cell elution | Feb 11, 1996 | Issued |